ICMR & NCDC Supports Kerala in Managing Nipah Case

Date:

Share post:

iHgh-level central health teams have arrived in Kozhikode to lead epidemiological investigations following a laboratory-confirmed case of Nipah virus in a 43-year-old individual.

Experts from the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC) are on the ground, collaborating closely with state revenue and district administration officials. The joint team immediately reviewed isolation protocols at the Government Medical College Hospital, where the patient is currently receiving advanced medical management, including specialized monoclonal antibody therapy.

In a reassuring development for public health officials, initial diagnostic tests conducted on the patient’s closest family members have returned negative. While these primary high-risk contacts are clear, health authorities have successfully mapped a contact list of 100 individuals to mitigate any risk of community transmission. Four additional symptomatic individuals have been moved to hospital isolation for preemptive monitoring.

Door-to-door health surveys and environmental surveillance of local fruit bat habitats are underway. The public is advised to remain calm, avoid spreading unverified information, and strictly adhere to health advisories issued by the department.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

FSSAI Bans Use of Metallic Pins and Wires in Food Packaging

India's food regulatory authority, FSSAI, has issued a strict advisory directing all Food Business Operators (FBOs) across the...

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the company had identified an IT security incident involving unauthorised access to...

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, Government of India, has...

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to...